Breaking News Instant updates and real-time market news.

NVS

Novartis

$80.83

0.38 (0.47%)

05:46
06/19/17
06/19
05:46
06/19/17
05:46

Sandoz receives EU appropval for Rixathon

Sandoz, a Novartis division, announced today that the European Commission, or EC, has approved Rixathon for use in Europe. Rixathon is approved for use in all indications of the reference medicine, MabThera. Rixathon is approved for non-Hodgkin's lymphoma and chronic lymphocytic leukemia, as well as immunological diseases such as rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.

  • 26

    Jun

NVS Novartis
$80.83

0.38 (0.47%)

06/01/17
NEED
06/01/17
NO CHANGE
Target $4.5
NEED
Buy
Cryoport price target raised to $4.50 from $3.50 at Needham
Needham analyst Sean Hannan noted that Novartis (NVS) and Kite Pharma (KITE) both have Biologics License Applications nearing approval for studies believed to be supported by Cryoport (CYRX). Citing his growing comfort on clients' progress toward commercialization, he raised his price target on Cryoport to $4.50 from $3.50 and keeps a Buy rating on the "arms provider" to companies working on emerging regenerative therapies.
06/06/17
LEER
06/06/17
NO CHANGE
Target $100
LEER
Outperform
bluebird data among most impressive in CAR-T space, says Leerink
Leerink analyst Michael Schmidt says bluebird bio's (BLUE) bb2121 dose-escalation data in multiple myeloma is among the most impressive early data sets he's seen in the CAR-T space to date. The data sets a high bar for the competition, which includes Juno Therapeutics (JUNO), Kite Pharma (KITE) and Novartis (NVS), Schmidt tells investors in a research note. Being one year ahead of the competition provides bluebird and Celgene (CELG) with an ideal position in multiple myeloma, the analyst adds. He keeps an Outperform rating on bluebird shares with a $100 price target.
06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/08/17
06/08/17
UPGRADE
Target $100

Buy
Kite Pharma upgraded to Buy on Axi-Cel manufacturing edge at BTIG
As previously reported, BTIG analyst Dane Leone upgraded Kite Pharma (KITE) to Buy from Neutral and set a $100 price target on the shares. Data from Novartis (NVS) and Juno (JUNO) have failed to deliver any recognizable differentiation, though Leone gives Kite "a clear win" for the manufacturing of Axi-Cel versus peers, he tells investors. The analyst sees Kite having the cleanest pathway to approval for diffuse large B-cell lymphoma and, given Kite's manufacturing edge, he estimates that Axi-Cel can take about 60% of share within the U.S. DLBCL market.

TODAY'S FREE FLY STORIES

07:55
01/17/18
01/17
07:55
01/17/18
07:55
General news
Fedspeak resumes along with a Senate vote on Powell »

Fedspeak resumes along…

CLR

Continental Resources

$56.93

-0.73 (-1.27%)

07:54
01/17/18
01/17
07:54
01/17/18
07:54
Downgrade
Continental Resources rating change  »

Continental Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PXD

Pioneer Natural

$182.51

-3.64 (-1.96%)

07:53
01/17/18
01/17
07:53
01/17/18
07:53
Downgrade
Pioneer Natural rating change  »

Pioneer Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

IPAS

iPass

$0.45

-0.0349 (-7.21%)

07:53
01/17/18
01/17
07:53
01/17/18
07:53
Initiation
iPass initiated  »

iPass initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYD

Boyd Gaming

$36.16

-0.32 (-0.88%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Initiation
Boyd Gaming initiated  »

Boyd Gaming initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$37.92

0.42 (1.12%)

, NURO

NeuroMetrix

$1.72

-0.06 (-3.37%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Technical Analysis
Technical Take: NeuroMetrix up sharply, GlaxoSmithKline strategic collaboration »

NeuroMetrix (NURO) was…

GSK

GlaxoSmithKline

$37.92

0.42 (1.12%)

NURO

NeuroMetrix

$1.72

-0.06 (-3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

  • 23

    Apr

MOBL

MobileIron

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Initiation
MobileIron initiated  »

MobileIron initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.64

-1.53 (-1.29%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Downgrade
PPG rating change  »

PPG downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

JEC

Jacobs Engineering

$69.42

-0.14 (-0.20%)

07:51
01/17/18
01/17
07:51
01/17/18
07:51
Hot Stocks
Jacobs wins engineering services agreement from Carcross/Tagish Energy »

Jacobs Engineering Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 07

    Feb

07:50
01/17/18
01/17
07:50
01/17/18
07:50
Conference/Events
UBS REITs analyst holds an analyst/industry conference call »

REITs Analyst Yulico,…

GM

General Motors

$44.19

0.12 (0.27%)

07:49
01/17/18
01/17
07:49
01/17/18
07:49
Periodicals
GM, DHL use Chinese plant to handle flow of parts, Reuters reports »

DHL employees have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

EGAN

eGain

$5.35

-0.35 (-6.14%)

07:48
01/17/18
01/17
07:48
01/17/18
07:48
Initiation
eGain initiated  »

eGain initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$221.53

0.3 (0.14%)

07:48
01/17/18
01/17
07:48
01/17/18
07:48
Recommendations
Netflix analyst commentary  »

Netflix checks suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 30

    Jan

XRAY

Dentsply Sirona

$65.65

-0.14 (-0.21%)

07:47
01/17/18
01/17
07:47
01/17/18
07:47
Hot Stocks
Dentsply Sirona adds three new board members »

Dentsply Sirona has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:47
01/17/18
01/17
07:47
01/17/18
07:47
General news
Futures suggest rebound from yesterday's dip »

Stock futures are higher…

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:47
01/17/18
01/17
07:47
01/17/18
07:47
Hot Stocks
Pearson: U.S. tax reform to result in one-off deferred tax charge in 2017 »

Pearson says, "Our…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Hot Stocks
Pearson sees FY18 adjusted operating profit GBP520M-GBP560M »

Pearson says, "In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$21.49

-0.83 (-3.72%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Initiation
Boingo Wireless initiated  »

Boingo Wireless initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

PSO

Pearson

$9.82

-0.08 (-0.81%)

07:46
01/17/18
01/17
07:46
01/17/18
07:46
Earnings
Pearson sees FY adjusted EPS above 49p-52p guidance range »

Adjusted earnings per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$81.91

-0.51 (-0.62%)

07:45
01/17/18
01/17
07:45
01/17/18
07:45
Technical Analysis
Technical Take: Adient falls sharply in pre-market, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

ESPR

Esperion

$71.91

-1.35 (-1.84%)

07:45
01/17/18
01/17
07:45
01/17/18
07:45
Recommendations
Esperion analyst commentary  »

Esperion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$68.78

-0.48 (-0.69%)

07:44
01/17/18
01/17
07:44
01/17/18
07:44
Recommendations
Lennar analyst commentary  »

Lennar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHYDY

Norsk Hydro

$7.60

-0.16 (-2.06%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Downgrade
Norsk Hydro rating change  »

Norsk Hydro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAST

Fastenal

$55.44

-0.15 (-0.27%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Earnings
Fastenal reports Q4 EPS 45c ex-tax benefit, consensus 45c »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

LBTYA

Liberty Global

$36.56

-0.31 (-0.84%)

07:43
01/17/18
01/17
07:43
01/17/18
07:43
Upgrade
Liberty Global rating change  »

Liberty Global upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.